<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Approach to the diagnosis of cholangiocarcinoma in a patient with primary sclerosing cholangitis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Approach to the diagnosis of cholangiocarcinoma in a patient with primary sclerosing cholangitis</h1>
<div class="graphic"><div class="figure"><div class="ttl">Approach to the diagnosis of cholangiocarcinoma in a patient with primary sclerosing cholangitis</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_footnotes">PSC: primary sclerosing cholangitis; CA 19-9: carbohydrate antigen 19-9; CEA: carcinoembryonic antigen; AFP: alpha-fetoprotein; MRCP: magnetic resonance cholangiopancreatography; CCA: cholangiocarcinoma; ERCP: endoscopic retrograde cholangiopancreatography; PET: positron emission tomography; CT: computed tomography; IDUS: intraductal ultrasound; PTC: percutaneous transhepatic cholangiography.<br/>* In patients with PSC, CCA should be considered if there is rapid clinical deterioration with jaundice, weight loss, and abdominal pain. The presence of progressive biliary dilatation in the setting of a dominant stricture or thickening of the bile duct wall should also raise a strong suspicion of CCA. CCA should also be considered if suggested by screening test results (ie, CA 19-9 and/or MRCP).<br/>¶ All patients suspected of having CCA should have tumor markers (CA 19-9, CEA, and for patients with intrahepatic lesions, AFP) checked. Elevated tumor markers may support a diagnosis of CCA or, in the case of an elevated AFP, suggest an alternative diagnosis (hepatocellular carcinoma). In patients with PSC, the optimal CA 19-9 cutoff (providing optimal balance between sensitivity and specificity) is approximately 100 to 129 units/mL.<br/>Δ If at any point during the evaluation, an alternative diagnosis is made, treatment should be instituted as appropriate for that diagnosis.<br/><font class="lozenge">◊</font> With brushings/biopsies of any intraductal lesions or strictures. Obstructing lesions can be stented if needed. If ERCP is nondiagnostic, consider cholangioscopy (if available) for direct visualization of the bile duct and biopsies. IDUS (if available) can be used to further define the extent of the tumor. If the lesion is not accessible endoscopically, consider PTC.<br/>§ If the diagnosis of CCA is strongly suspected but imaging has been nondiagnostic. Preoperative PET/CT scan may also help guide surgery by identifying areas more likely to harbor malignancy.<br/>¥ If the patient is a surgical candidate.</div><div id="graphicVersion">Graphic 96373 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
